NavSTAR program for opioid use disorder
Part of Mental health clinical trials.
This trial tests a program to help people with opioid use disorder start or continue treatment while in the hospital. It aims to connect patients to care after they leave.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe opioid use disorder (confirmed by a doctor).
- You can understand and agree to participate in English.
- You live in the City of Philadelphia.
- You are not currently pregnant.
- You have not been in opioid treatment in the 30 days before entering the hospital.
- You are not being discharged to a long-term facility like a nursing home or hospice.
- You are not in the hospital because of a suicide attempt.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.
This study tests a program called YORS that helps teens with opioid use disorder stick with their medication. It involves you and a support person (like a parent) working together with the study team to stay on track.
This study tests a program to help new mothers recovering from opioid use disorder by involving a support person. It aims to improve recovery and well-being during the first weeks after childbirth.
This study tests whether a smartphone app and support from a peer recovery coach can help Black and Latinx individuals with opioid use disorder start buprenorphine treatment. The goal is to reduce overdose deaths and address racial gaps in care.
This study tests a structured recovery support program for adults age 18–28 who have opioid use disorder. It may help by adding extra involvement and support while you receive common long-acting opioid treatment from a medical clinic.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.